Long-acting interleukin-15 receptor agonist in combination with another pharmacologically active agent
CA3112834A1
Method of making releasable polymeric reagents
KR20210002577A
Selective TREG stimulant RUR20kD-IL-2 and related compositions
EP3706770A1
Immunotherapeutic combination for treating cancer
US2019046523A1
Oligomer-opioid agonist conjugates
AU2018316694A1
Immunotherapeutic tumor treatment method
WO2019023368A1
Oral tablet formulations
WO2018213341A1
Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methods
AU2018261102A1
Immunotherapeutic tumor treatment method
WO2018160877A1
Immunotherapeutic tumor treatment method using an interleukin-2 receptor alpha, beta-selective agonist in combination with adoptive cell transfer therapy
US2018296550A1
Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound
MX2019008276A
Multi-arm polymer conjugates of tlr agonist compounds and related immunotherapeutic treatment methods.
CN109890406A
Immunotherapy of tumors treatment method
CN109475639A
Conjugates with the bonded Factor VIB moiety containing oxime
US2017253565A1
Opioid agonists and uses thereof
WO2017127420A1
Sealed liquid reservoir for a nebulizer
CN108135978A
The combination of IL-2R beta selective agonists and long-acting IL-15 agonists
